Lifecore Biomedical (LFCR) Misses Q3 EPS by 81c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts LFCR Hot Sheet
Join SI Premium – FREE
Lifecore Biomedical (NASDAQ: LFCR) reported Q3 EPS of ($1.08), $0.81 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $25.3 million versus the consensus estimate of $27.37 million.
For earnings history and earnings-related data on Lifecore Biomedical (LFCR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ACM Research (ACMR) Tops Q3 EPS by 6c ; Offers Guidance
- Ducommun Inc. (DCO) Tops Q3 EPS by 6c
- Cedar Fair L.P. (FUN) Misses Q3 EPS by 557c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
